🚀 VC round data is live in beta, check it out!
SANUWAVE Health Valuation Multiples
Discover revenue and EBITDA valuation multiples for SANUWAVE Health and similar public comparables like Sanara MedTech, Quanterix, Quantum-Si, Vuno and more.
SANUWAVE Health Overview
About SANUWAVE Health
SANUWAVE Health Inc is an ultrasound and shock wave technology company using patented systems of noninvasive, high-energy, acoustic shock waves or low-intensity and non-contact ultrasound for regenerative medicine and other applications. The company's focus is regenerative medicine utilizing noninvasive, acoustic shock waves or ultrasound to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's two primary systems are UltraMIST and PACE. UltraMIST and PACE are the only two Food and Drug Administration (FDA) approved directed energy systems for wound healing.
Founded
2004
HQ
Employees
46
Website
Sectors
Financials (LTM)
EV
$167M
SANUWAVE Health Financials
SANUWAVE Health reported last 12-month revenue of $46M and EBITDA of $14M.
In the same LTM period, SANUWAVE Health generated $36M in gross profit, $14M in EBITDA, and $10M in net income.
Revenue (LTM)
SANUWAVE Health P&L
In the most recent fiscal year, SANUWAVE Health reported revenue of $44M and EBITDA of $19M.
SANUWAVE Health expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $46M | XXX | $44M | XXX | XXX | XXX |
| Gross Profit | $36M | XXX | $34M | XXX | XXX | XXX |
| Gross Margin | 77% | XXX | 77% | XXX | XXX | XXX |
| EBITDA | $14M | XXX | $19M | XXX | XXX | XXX |
| EBITDA Margin | 31% | XXX | 44% | XXX | XXX | XXX |
| EBIT Margin | 12% | XXX | 11% | XXX | XXX | XXX |
| Net Profit | $10M | XXX | $12M | XXX | XXX | XXX |
| Net Margin | 21% | XXX | 27% | XXX | XXX | XXX |
| Net Debt | — | — | $10M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
SANUWAVE Health Stock Performance
SANUWAVE Health has current market cap of $156M, and enterprise value of $167M.
Market Cap Evolution
SANUWAVE Health's stock price is $18.15.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $167M | $156M | 3.5% | XXX | XXX | XXX | $1.37 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialSANUWAVE Health Valuation Multiples
SANUWAVE Health trades at 3.6x EV/Revenue multiple, and 11.6x EV/EBITDA.
EV / Revenue (LTM)
SANUWAVE Health Financial Valuation Multiples
As of April 11, 2026, SANUWAVE Health has market cap of $156M and EV of $167M.
Equity research analysts estimate SANUWAVE Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
SANUWAVE Health has a P/E ratio of 16.3x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $156M | XXX | $156M | XXX | XXX | XXX |
| EV (current) | $167M | XXX | $167M | XXX | XXX | XXX |
| EV/Revenue | 3.6x | XXX | 3.8x | XXX | XXX | XXX |
| EV/EBITDA | 11.6x | XXX | 8.6x | XXX | XXX | XXX |
| EV/EBIT | 29.9x | XXX | 33.8x | XXX | XXX | XXX |
| EV/Gross Profit | 4.7x | XXX | 4.9x | XXX | XXX | XXX |
| P/E | 16.3x | XXX | 13.2x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 86.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified SANUWAVE Health Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
SANUWAVE Health Margins & Growth Rates
SANUWAVE Health's revenue in the last 12 month grew by 20%.
SANUWAVE Health's revenue per employee in the last FY averaged $1.0M, while opex per employee averaged $0.6M for the same period.
SANUWAVE Health's rule of 40 is 49% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
SANUWAVE Health's rule of X is 77% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
SANUWAVE Health Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 20% | XXX | 18% | XXX | XXX | XXX |
| EBITDA Margin | 31% | XXX | 44% | XXX | XXX | XXX |
| EBITDA Growth | 25% | XXX | (16%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 49% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 77% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $1.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.6M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 17% | XXX | 17% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 43% | XXX | 44% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 3% | XXX | 3% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 66% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
SANUWAVE Health Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Sanara MedTech | XXX | XXX | XXX | XXX | XXX | XXX |
| Quanterix | XXX | XXX | XXX | XXX | XXX | XXX |
| Quantum-Si | XXX | XXX | XXX | XXX | XXX | XXX |
| Vuno | XXX | XXX | XXX | XXX | XXX | XXX |
| Pro-Dex | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
SANUWAVE Health M&A Activity
SANUWAVE Health acquired XXX companies to date.
Last acquisition by SANUWAVE Health was on XXXXXXXX, XXXXX. SANUWAVE Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by SANUWAVE Health
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialSANUWAVE Health Investment Activity
SANUWAVE Health invested in XXX companies to date.
SANUWAVE Health made its latest investment on XXXXXXXX, XXXXX. SANUWAVE Health invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by SANUWAVE Health
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout SANUWAVE Health
| When was SANUWAVE Health founded? | SANUWAVE Health was founded in 2004. |
| Where is SANUWAVE Health headquartered? | SANUWAVE Health is headquartered in United States. |
| How many employees does SANUWAVE Health have? | As of today, SANUWAVE Health has over 46 employees. |
| Who is the CEO of SANUWAVE Health? | SANUWAVE Health's CEO is Morgan C. Frank. |
| Is SANUWAVE Health publicly listed? | Yes, SANUWAVE Health is a public company listed on Nasdaq. |
| What is the stock symbol of SANUWAVE Health? | SANUWAVE Health trades under SNWV ticker. |
| When did SANUWAVE Health go public? | SANUWAVE Health went public in 2008. |
| Who are competitors of SANUWAVE Health? | SANUWAVE Health main competitors are Sanara MedTech, Quanterix, Quantum-Si, Vuno. |
| What is the current market cap of SANUWAVE Health? | SANUWAVE Health's current market cap is $156M. |
| What is the current revenue of SANUWAVE Health? | SANUWAVE Health's last 12 months revenue is $46M. |
| What is the current revenue growth of SANUWAVE Health? | SANUWAVE Health revenue growth (NTM/LTM) is 20%. |
| What is the current EV/Revenue multiple of SANUWAVE Health? | Current revenue multiple of SANUWAVE Health is 3.6x. |
| Is SANUWAVE Health profitable? | Yes, SANUWAVE Health is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of SANUWAVE Health? | SANUWAVE Health's last 12 months EBITDA is $14M. |
| What is SANUWAVE Health's EBITDA margin? | SANUWAVE Health's last 12 months EBITDA margin is 31%. |
| What is the current EV/EBITDA multiple of SANUWAVE Health? | Current EBITDA multiple of SANUWAVE Health is 11.6x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.